Pulsed Delivery of Inhaled Nitric Oxide to Patients With Primary Pulmonary Hypertension
Authors:
- John W. NewhartJNJohn W. Newhart
- F. Wayne JohnsonFJF. Wayne Johnson
- Penny J. WilliamsPWPenny J. Williams
- William R. AugerWAWilliam R. Auger
- Peter F. FedulloPFPeter F. Fedullo
- Kenneth M. MoserKMKenneth M. Moser
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Inhaled Nitric Oxide Reverses Hypoxic Pulmonary Vasoconstriction in DogsChest, 1994
- Improvement In Pulmonary Hypertension And Hypoxemia During Nitric Oxide Inhalation In A Patient With End-Stage Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 1994
- Inhaled nitric oxide in congenital heart disease.Circulation, 1993
- The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary HypertensionNew England Journal of Medicine, 1992
- Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertensionThe Lancet, 1991
- An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.Proceedings of the National Academy of Sciences, 1990
- Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein.Circulation Research, 1989
- Vascular endothelial cells synthesize nitric oxide from L-arginineNature, 1988
- Primary Pulmonary HypertensionAnnals of Internal Medicine, 1987
- Endothelium‐dependent inhibition of platelet aggregationBritish Journal of Pharmacology, 1986